one possible explanation for the focal nature of renal cyst formation (Qian et al., 1996; Brasier and Henske, 1997). We observed loss of heterozygosity (LOH) have also been associated with renal cystic disease Type I is a common genetic disorder and an important (Brook-Carter et al., 1994) , it was suggested that somatic cause of renal failure. The disease is characterized involvement of TSC2 might be critical in the process of by progressive cyst formation in a variety of organs cystogenesis (Ong and Harris, 1997). including the kidney, liver and pancreas. We have pre-
Introduction level.
Autosomal dominant polycystic kidney disease (ADPKD)
Results and Discussion is a common genetic disorder with a prevalence at birth estimated to be 1:400-1:1000 (Iglesias et al., 1983; Ga- To examine the genetic basis of liver cyst formation, bow, 1993). Mutations in the PKD1 gene on chromosome DNA was isolated from the liver cysts of two donors, 16 account for ‫%59-%58ف‬ of clinically recognized cases, JHU415 (12 cysts) and JHU452 (9 cysts). Techniques while the remainder are largely caused by mutations in designed to maintain cyst wall integrity and to minimize PKD2 on chromosome 4 (Peters and Sandkuijl, 1992;  contamination from surrounding cells were employed The European Polycystic Kidney Disease Consortium, (Qian et al., 1996) . The donors were then screened for the 1994; The American PKD1 Consortium, 1995; Mochizuki presence of polymorphisms at two well-characterized et al., 1996) . Renal cyst formation is a universal feature intragenic loci, KG8 and EJ1, that could be used to test and leads to renal failure in approximately 50% of disthe cysts for loss of heterozygosity (LOH) (Figure 1 ) ease gene carriers. In addition, affected individuals may (Snarey et al., 1994; Qian et al., 1996) . The first donor, exhibit a variable combination of extrarenal manifesta-JHU415, was informative only at EJ1 while JHU452 was tions including hepatic and pancreatic cysts, cerebral uninformative for both markers (data not shown). aneurysms, and cardiac valvular abnormalities (Iglesias Heteroduplex analysis of EJ1 for liver cysts from et al., 1983; Kaehny and Everson, 1991; Everson, 1993;  JHU415 is shown in Figure 2A and demonstrates LOH Gabow, 1993) . A common feature of each of these findfor this marker in cysts (C) 8 and 12. Mixing studies using ings is that they result from a focal process involving defined cloned alleles (A1-A3) suggested that both cysts only a subset of cells in each of the target organs. This with LOH lacked the A1 allele and that the remaining observation suggests that a second, possibly rate-limallele was neither A2 nor A3 ( Figure 2B ). This was coniting, step might be required for the pathogenic changes firmed by determining the sequence of cloned EJ1 alto occur in each tissue.
leles from the blood sample of JHU415. As predicted, Recent studies by our group and others have provided in addition to A1, JHU415 was found to contain a C-to-G transversion in exon 45 (cDNA base pair 12589, GenBank accession number L33243) that creates a prema- § To whom correspondence should be addressed (e-mail: ggermino @welchlink.welch.jhu.edu).
ture stop codon and a new MaeI site. This germline The PKD1 gene contains 46 exons and is bisected by a polypyrimidine tract of ‫5.2ف‬ kb (hatched box). The replicated portion of the gene begins in exon 1 and ends in intron 34 (stippled bar). The locations of polymorphisms used for LOH studies and haplotype analysis are indicated. The positions of PKD1-specific, long-range PCR products, 3ЈLR ‫01ف(‬ kb) and 5ЈMR ‫3ف(‬ kb), are shown along with the primers used for amplification.
mutation, which was also present in an affected sibling Once the germline mutation was identified, it was possi-(data not shown), is predicted to result in a truncated ble to confirm by restriction digest that this was the only protein lacking the intracytoplasmic coiled-coil portion allele remaining in both cysts with LOH ( Figure 2C ). of the PKD1 gene. This domain is functionally important Interestingly, one additional cyst (Figure 2A , C11) from because it is thought to mediate binding to the PKD2 liver donor JHU415 demonstrated an unusual EJ1 hetergene product (Qian et al., 1997; Tsiokas et al., 1997) .
oduplex pattern. We cloned EJ1 from this cyst and two distinct classes of clones were identified by sequencing. One group had the germline stop codon (N ϭ 5), while the other contained a 2 bp (base pair) (GC) insertion ( Table 1) that is predicted to result in a truncated protein after the addition of 12 novel amino acids (N ϭ 5). The insertion creates a new BstUI site that is present in the cyst sample but not in the donor's blood DNA ( Figure  2D ). Taken together, these data indicate that C11 has acquired a unique somatic mutation on the normal haplotype.
Since the second donor, JHU452, was uninformative for both KG8 and EJ1, we decided to screen this individual for additional intragenic polymorphic markers that could be used to test for LOH. We chose to focus on the 5Ј region of the gene since we had small quantities of cyst DNA and previous mutation studies suggested that this area is likely to harbor most of the sequence variation (Peral et al., 1996) . Until recently, analysis of this portion of PKD1 was virtually impossible since ‫%07ف‬ of the gene, from exon 1 to exon 34 (Figure 1 ), A3 were mixed separately with radiolabeled EJ1 that was amplified from each cyst. The mix was analyzed for heteroduplex formation. The addition of A1 to the control cyst did not alter the preexisting heteroduplex pattern, while it restored the control pattern in C8 and C12. Addition of A2 and A3 to each cyst produced novel heteroduplex patterns. C11 exhibited mixing patterns similar to those of C8 and C12 but there were also new bands at the top of the gel that are not shown. (C) A fragment of EJ1 (FQF28-C12R1) was amplified from the blood of JHU415 and C12 and digested with MaeI. Both uncut (normal) and cut (mutant) products are present in the blood of JHU415 (lane 2), while only the cut product (mutant) remains in C12 (lane 1). A similar result was obtained for C8 (data not shown). Lane 3 shows Figure 2 . Loss of Heterozygosity (LOH) for EJ1 in Cysts from Liver the undigested product from blood. A restriction map, along with Donor JHU415 the relative position of primers used for amplification, is shown. The 52 bp fragment is not shown. (A) EJ1 was amplified from the blood of JHU415 as well as DNA isolated from 12 liver cysts and subjected to heteroduplex analysis.
(D) A fragment of EJ1 (C12F1-FQR35) was amplified from a clone containing the normal allele (lanes 1 and 2), a clone containing the The majority of cysts (C) have the same pattern as the blood. C8 and C12, however, demonstrate LOH since heteroduplex formation 2 bp insertion (lanes 3 and 4), the blood of JHU415 (lanes 5 and 6), and C11 (lanes 7 and 8). Undigested products (lanes 1, 3, 5, and 7) is no longer seen. C11 shows a novel heteroduplex pattern. (B) Mixing studies were performed to determine which EJ1 allele and products digested with BstUI (lanes 2, 4, 6, and 8) are analyzed on a Nusieve gel. A BstUI restriction map is shown along with the remained in cysts with either LOH (C8, C12) or a novel heteroduplex pattern (C11). A cyst sample, C1, with a pattern representative of approximate position of the primers used to amplify the subfragment of EJ1. (M) represents the marker lane. blood was included as a control. Unlabeled EJ1 alleles A1, A2, and is present in multiple highly homologous copies on chroAlthough none of the 9 cysts demonstrated LOH for either of these intragenic markers, mutation analysis mosome 16 (Germino et al., 1992 ; The European Polyusing 3ЈLR and 5ЈMR amplified from cyst DNA revealed cystic Kidney Disease Consortium, 1994). We have deunique heteroduplex patterns in five cysts. Each variant veloped a novel strategy for mutation analysis in the was sequenced and the results are summarized in Table  duplicated region of PKD1 that allows us to circumvent 1. Two cysts contained intragenic deletions, one in exon the difficulties posed by the homologous loci (Watnick 23 and the other in exon 30. The deletion in exon 30 et al., 1997). Our method uses gene-specific primers was predicted to disrupt a consensus splice donor site located in two areas of PKD1 to amplify large segments ( Figure 4 ). In addition, three cysts were found to have of the gene that can be used for mutation studies. We single base pair changes. Two of these were predicted were able to use two of these PKD1-specific templates to result in nonsense mutations in exons 19 and 24. The (3ЈLR and 5ЈMR, Figure 1 ) amplified from the blood DNA third was a nonconservative amino acid change in exon of JHU452 to screen exons 16-34 (excluding exon 22) 23. In each case, the "mutation" was shown to be absent via heteroduplex analysis. Two sequence variants were from the germline of JHU452 (PKD1 and homologs), identified in the germline of JHU452. The first, PG1, is indicating that these changes were independent soa silent T-to-C transition (T7376C) in exon 17 that is matic events (data not shown). found in ‫%52ف‬ of normal samples (data not shown).
The informative polymorphisms in exons 17 (PG1) and The second variant (PG2) is located in exon 25 and 25 (PG2) were then used to establish the haplotype for is predicted to lead to a nonconservative amino acid each pathogenic sequence variant (deletions and stop change, substituting glutamine for arginine (A9258G, codons) using a variety of techniques. For the C8 stop Q3016R). This latter change was not found in a screen codon in exon 19, a fragment linking exon 17 to 19 was of 100 normal chromosomes (data not shown). Pedigree amplified and cloned from an appropriately diluted longanalysis indicates that both PG1 and PG2, which can range template. Nine clones were analyzed for the presbe assayed by restriction digest, segregate with the ence of PG1 and the exon 19 stop codon. Clones condisease phenotype in the family of JHU452 (Figure 3) . tained either the stop codon or PG1 but not both. The remaining cysts were analyzed using primers that could distinguish between mutant and normal alleles. PCR products were amplified directly from cyst DNA using an allele-specific primer in combination with an exon 25 primer and then tested for the absence or presence of PG2 by MspI digestion. Characterization of the exon 30 deletion is shown in Figure 4 as a representative example. In each case, the mutation was found to occur on the normal haplotype.
In this report, we demonstrate that a second focal manifestation of ADPKD is associated with somatic inactivation of the normal PKD1 allele. We have used novel methods to address several issues raised in response to our initial findings in renal cysts. Our data suggest that with the use of adequately sensitive techniques, it is possible to detect inactivating mutations in a large fraction of cysts. The loss of PKD1 alone appears to be Collectively, these data support a recessive molecular model for ADPKD, Type I. Most, if not all, cysts are likely to be comprised of a unique combination of germline and somatic mutations. It is reasonable to speculate that all focal manifestations of the disease result from a similar process. The factors governing the rate of second hits have yet to be defined and may involve a combination of genetic and environmental determinants.
Experimental Procedures
Preparation of Cyst DNA DNA was prepared from the individual liver cysts of two donors (JHU415 and JHU452) using techniques described in detail elsewhere (Qian et al., 1996) . Briefly, the contents of each cyst were drained using a needle/syringe, and the needle was left in the cyst for the duration of the procedure. The cavity of the cyst was rinsed a minimum of three times with Ca 2ϩ -and Mg 2ϩ -free PBS. Then, PBS containing 2 mM EDTA was injected into the lumen of the cyst and incubated for 20 min. The cyst contents were collected and the DNA extracted using the Puregene DNA extraction kit (Gentra).
EJ1 Analysis of JHU415
The polymorphic locus EJ1 was identified by heteroduplex analysis of a PCR product containing a portion of exons 45 and 46 as well as the intervening intron (Qian et al., 1996) . EJ1 is amplified using the primers FQF28 (5Ј-CACGCCTTGCGTGGAGAG-3Ј) and FQR35 (5Ј-ATGGGCCACGGGAAGATCC-3Ј). The sequence of the three alleles, A1-A3, that account for the polymorphism has been previously reported along with methods for performing mixing studies with cloned alleles (Qian et al., 1996) . The EJ1 alleles from the blood DNA of JHU415 and C11 were cloned into pCRII (Invitrogen). Two independent clones containing each allele were sequenced using an ABI automated sequencer. To test for the presence of the germline MaeI site, a nested PCR product of 329 bp was amplified using primers FQF28 and C12R1 (5Ј-GAGGTGGAGGGGTGCGAG-3Ј). The BstUI site in C11 was also assayed using a nested product of 391 bp amplified using primers C12F1 (5Ј-CTCTGCCCAGGGTGCAGC-3Ј) and FQR35.
Long-Range PCR 300 ng of genomic DNA (isolated from whole blood using the Puregene kit) or 5 l of cyst DNA was used as template for amplification Figure 4 . C4 Contains a 20 bp Deletion on the Normal Haplotype of two long-range, gene-specific templates, 3ЈLR and 5ЈMR. The that Disrupts a Consensus Splice Site in Intron 30 PCR conditions and primer sequences used to generate 3ЈLR ‫01ف(‬ (A) Intron-based primers were used to amplify exon 30 from the kb) have been published elsewhere (Watnick et al., 1997) . 5ЈMR ‫3ف(‬ 3ЈLR of JHU452 and nine individual cysts. The radiolabeled PCR kb) was amplified using a PKD1-specific primer (FQF26, 5Ј-AGCGC products were subjected to heteroduplex analysis. C4 contains a AACTACTTGGAGGCCC-3Ј) located in exon 15 and another primer novel heteroduplex pattern.
(TWR2, 5Ј-GCAGGGTGAGCAGGTGGGGCCATCCTA-3Ј) located in (B) A PCR product spanning exons 25-30 was amplified from the intron 21 prior to the polypyrimidine tract in that intron. The specific-3ЈLR of C4. This product was cloned and sequenced, and a 20 bp ity of 5ЈMR was verified using strategies reported previously for deletion was identified at the exon 30 splice donor site. The se-3ЈLR (Watnick et al., 1997). The PCR conditions for 5ЈMR are as quence of the mutant allele is demonstrated in the reverse orientafollows: 95ЊC for 3 min, 35 cycles of 95ЊC for 20 s, and 70ЊC for 4 tion, and the deleted base pairs are noted. To clarify the effect of min and a final extension of 72ЊC for 10 min. The total PCR volume this mutation, the sequences of normal (N) and mutant (M) alleles was 50 l using 4 U of rTth DNA polymerase XL (Cetus, Perkin are noted below in the forward orientation. The vertical bar identifies Elmer) and a final Mg ϩ concentration of 1.1 mM. The long-range the position of the exon/intron boundary for the end of exon 30.
templates were serially diluted to (1:10 4 or 1:10 5 ) to remove genomic The dashes represent the deleted base pairs. The arrow shows the contamination. sequence of a primer that was designed to amplify only the mutant allele. (C) The "mutant"-specific primer was used to amplify a PCR product of ‫3ف‬ kb spanning exons 25-30 directly from cyst DNA (lane 3). This primer would not support amplification from either the blood (lane with MspI and analyzed on a Nusieve gel. Exon 25 amplified from 2) or the 3ЈLR (data not shown) of JHU452. A clone with the deletion the mutant-specific product did not cut with MspI, indicating that (lane 1) is included as a positive control. This demonstrates the the PCR product does not contain PG2. Since this polymorphism specificity of the primer and suggests that the deletion was a sosegregates with the disease phenotype in the family of JHU452, the matic event not present in the germline of JHU452.
deletion occurred on the normal haplotype. The mutant-specific (D) Exon 25 was amplified from the mutant-specific PCR product PCR product was diluted to 1:10 4 for nested amplification of exon shown in (C) (lane 3), a clone containing the PG2 polymorphism 25 to ensure that there was no contamination of cyst DNA (data not (lane 1), and the 3ЈLR of JHU452 (lane 2). The products were digested shown). (1991) . Extrarenal manifestations alleles as described in the text. Conditions for PCR were optimized of autosomal dominant polycystic kidney disease. Semin. Nephrol. using clones that contained mutant or normal sequences, and the 11, 661-670. blood DNA of JHU452 was always used as a negative control. In Kwok, S., Kellogg, D.E., McKinney, N., Spasic, D., Goda, L., Leventhe case of C4, the primer (5Ј-CATTCCCAGTACTCCCCCTTG-3Ј) son, C., and Sninsky, J.J. (1990) . Effects of primer-template miswas designed to span the deletion breakpoint in exon 30 (Figure 4) . matches on the polymerase chain reaction: human immunodefiAlternatively, for C2 a primer specific for the exon 24 stop codon was ciency virus type 1 model studies. Nucleic Acids Res. 18, 999-1005. designed (5Ј-AGGATCCGCCCAGAGGG-3Ј) by placing the C-to-G Lu, W., Peissel, B., Babakhanlou, H., Pavlova, A., Geng, L., Fan, X., mismatch at the 3Ј end of the primer and introducing another intenLarson, C., Brent, G., and Zhou, J. (1997) . Perinatal lethality with tional mismatch (T-to-G) at the second 3Ј base pair. The intentional kidney and pancreas defects in mice with targeted PKD1 mutation. mismatch was chosen to destabilize primer binding to the "normal Nat. Genet. 17, 179-181. sequence" using established guidelines (Kwok et al., 1990) . The presence of a local sequence reduplication around the C9 exon 23
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